MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA CH; ATELLICA CH VALPROIC ACID (VPA)

Model Number	N/A
Medical Device Problem Code	High Test Results (2457)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	01/27/2024
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
An outside of the united states (ous) customer contacted the siemens healthcare diagnostics remote services center (rsc) regarding a falsely elevated valproic acid (vpa) result obtained on a patient sample on an atellica ch 930 analyzer.Siemens is investigating the event.
Event or Problem Description
A discordant falsely elevated valproic acid (vpa) result was obtained on a patient sample when the sample was reprocessed on an atellica ch 930 analyzer.The falsely elevated result was not reported to the physician(s).The initial low result obtained for the same sample on the previous day was reported as the correct result to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the falsely elevated valproic acid (vpa) result.
Additional Manufacturer Narrative
Additional information (21-mar-2024): siemens healthcare diagnostics headquarters support center (hsc) concluded the investigation of the event.Hsc reviewed the instrument data files and the information provided by the customer.Quality control (qc) recovered within the customer¿s expected ranges on the event date.Hsc observed no atypical performance and no processing errors.The vpa assay was performing acceptably.A siemens customer service engineer (cse) was dispatched to the customer¿s site on 21-feb-2024.The cse identified gel within the dilution probe and level sense errors at the reagent 1 drain.After the full service visit, qc recovered within the customer's expected ranges.The siemens service activities performed at the customer site were approximately one month after the event was observed and not between the time period of erroneously elevated and its acceptable result.Hence, the hsc cannot confirm that the hardware mitigations supported the erroneously elevated vpa result.Hsc concluded that a unique hardware event and/or pre-analytical variables for the patient sample could not be ruled out.The cause of the event is unknown.The customer is operational.The device is performing within specifications.No further evaluation is required.Has been updated to reflect the hsc investigation.Initial mdr 2432235-2024-00043 was filed on 04-mar-2024.

• Brand Name: ATELLICA CH
• Common Device Name: ATELLICA CH VALPROIC ACID (VPA)
• Manufacturer (Section D): SIEMENS HEALTHCARE DIAGNOSTICS INC.; 511 benedict ave; tarrytown NY 10591
• Manufacturer (Section G): SIEMENS HEALTHCARE DIAGNOSTICS INC.; registration # 2517506; 500 gbc drive, po box 6101; newark DE 19714 6101
• Manufacturer Contact: linda barletta ; 500 gbc drive; po box 6101; newark, DE 19714-6101
• MDR Report Key: 18824925
• Report Number: 2432235-2024-00043
• Device Sequence Number: 14192440
• Product Code: LEG
• UDI-Device Identifier: 00630414596013
• UDI-Public: 00630414596013
• Combination Product (Y/N): N
• Initial Reporter Country: BR
• PMA/510(K) Number: K982880
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Foreign,Health Professional,User Facility
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 04/10/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 07/09/2024
• Device Model Number: N/A
• Device Catalogue Number: SMN 11097512
• Device Lot Number: 130259
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Initial
• Initial Date Received by Manufacturer: 02/07/2024
• Supplement Date Received by Manufacturer: 03/21/2024
• Initial Report FDA Received Date: 03/04/2024
• Supplement Report FDA Received Date: 04/10/2024
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 07/10/2023
• Is the Device Labeled for Single Use? (Y/N): No
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Patient Age: 30 YR
• Patient Sex: Female